Photodynamic therapy treatment for eyes with drusenoid pigment epithelium detachment.
We report the clinical course of photodynamic therapy (PDT) in a patient with drusenoid pigment epithelium detachment (PED). A patient with drusenoid PED underwent PDT follow-up was carried out at one week, one month, three months, six months and one year after treatment. Fundus exam, optical coherence tomography (OCT) and fluorescein angiography were performed. After the PDT, drusen and PED were gradually diminished over one year. However, pure serous PED eventually developed at the same location of the drusenoid PED. The results of the PDT, on drusenoid PED, were initially effective, but not completely successful. Therefore, PDT may be considered as an alternative treatment option for drusenoid PED.
Lee
Na Young
NY
Department of Ophthalmology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim
Ki Seok
KS
D000368:Aged; D005451:Fluorescein Angiography; D006801:Humans; D008297:Male; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D010857:Pigment Epithelium of Eye / Q000187:drug effects* / Q000473:pathology; D011166:Porphyrins / Q000627:therapeutic use*; D012163:Retinal Detachment / Q000175:diagnosis / Q000188:drug therapy*; D015593:Retinal Drusen / Q000175:diagnosis / Q000188:drug therapy*; D041623:Tomography, Optical Coherence; D000077362:Verteporfin
D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin
Am J Ophthalmol. 2001 May;131(5):541-60
11336929
Br J Ophthalmol. 2004 May;88(5):638-42
15090415
Arch Ophthalmol. 1999 Oct;117(10):1329-45
10532441
Ophthalmology. 1999 Jul;106(7):1367-73; discussion 1374
10406624
Graefes Arch Clin Exp Ophthalmol. 2002 Jul;240(7):533-8
12136282
Br J Ophthalmol. 1998 Oct;82(10):1169-74
9924306